Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Beijing Tide Pharmaceutical patents PROTACs targeting mutant EGFR

July 13, 2021

Debiopharm identifies new enoyl-(acyl-carrier protein) reductase FabI inhibitors

July 13, 2021

New protein O-GlcNAcase inhibitors discovered at Janssen Pharmaceutica

July 12, 2021

Sinovent patents CDK7/cyclin H inhibitors

July 12, 2021

New influenza A virus vaccine synthesized at the University of Gdansk

July 12, 2021

Shire Human Genetic Therapies describes IDS gene therapy

July 12, 2021

Genentech patents anti-LY6G6D antibodies for colorectal cancer

July 9, 2021

Janssen Pharmaceutica discloses new OGA inhibitors

July 9, 2021

U.S. Department of Health & Human Services divulges compounds for HIV infection

July 9, 2021

Landos Biopharma patents new LANCL2 activators

July 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....